STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$5.96
-0.06 (-1.00%)
Financial Highlights (FY 2026)
Revenue
6.21M
Net Income
-81,821,809
Gross Margin
—
Profit Margin
-1,318.1%
Rev Growth
-42.5%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 47.5% | 47.5% |
| Operating Margin | -1,408.3% | -1,267.4% | 5.1% | 5.8% |
| Profit Margin | -1,318.1% | -1,252.2% | 3.7% | 4.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 6.21M | 10.78M | 31.76M | 28.92M |
| Gross Profit | — | — | 15.09M | 13.75M |
| Operating Income | -87,407,305 | -136,692,570 | 1.63M | 1.67M |
| Net Income | -81,821,809 | -127,957,650 | 1.18M | 1.33M |
| Gross Margin | — | — | 47.5% | 47.5% |
| Operating Margin | -1,408.3% | -1,267.4% | 5.1% | 5.8% |
| Profit Margin | -1,318.1% | -1,252.2% | 3.7% | 4.6% |
| Rev Growth | -42.5% | -42.5% | -3.0% | +24.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 82.62M | 102.31M |
| Total Equity | — | — | 173.07M | 148.25M |
| D/E Ratio | — | — | 0.48 | 0.69 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -83,281,240 | -137,475,548 | 2.48M | 2.21M |
| Free Cash Flow | — | — | 903.7K | 487.2K |